Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | -4.52% | 48.58 | 0.0% | $711.87m | |
| GWPH | GW Pharmaceuticals Plc | -0.28% | 214.25 | 6.1% | $393.29m | |
| HZNP | Horizon Therapeutics Plc | 0.38% | 90.91 | 5.5% | $197.75m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.58% | 168.04 | 2.3% | $189.90m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.58% | 31.46 | 14.1% | $185.11m | |
| BHC | Bausch Health Cos., Inc. | 0.58% | 31.46 | 0.0% | $141.41m | |
| CTLT | Catalent, Inc. | 1.07% | 113.45 | 2.1% | $115.20m | |
| ICLR | ICON plc | -2.04% | 180.68 | 4.2% | $96.12m | |
| ARGX | argenx SE | -2.59% | 330.68 | 0.0% | $81.80m | |
| PRGO | Perrigo Co. Plc | -1.64% | 40.11 | 6.8% | $71.31m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | -2.46% | 1.19 | 0.2% | $66.62m | |
| ZYNE | Zynerba Pharmaceuticals, Inc. | 0.79% | 4.50 | 6.0% | $58.84m | |
| AMRN | Amarin Corp. Plc | -3.02% | 6.74 | 1.5% | $49.30m | |
| UTHR | United Therapeutics Corp. | -0.96% | 167.18 | 14.1% | $44.01m | |
| PBH | Prestige Consumer Healthcare, Inc. | 0.12% | 41.82 | 4.0% | $40.75m |
Company Profile
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.